
may pm et
summari diversifi technolog compani provid advanc scientif technic product
servic world-wide pharmaceut industri market
price-to-earnings oper ep
risk assess reflect broad product mix
divers global client base howev compani
activ restructur busi unit product
portfolio well pursu acquisit could
past perform indic futur perform reli upon
analysi prepar equiti analyst
feb pm stock trade
expect sale includ
acqusit immun medic laboratori
tulip diagnost rise
follow rise account
may sale medic imag unit
report segment diagnost
discoveri analyt solut within
diagnost see solid growth
screen busi strong newborn
prenat sale growth particularli eastern
europ china stabil
within discoveri analyt solut
expect biopharmaceut food safeti
demand drive growth
medic laboratori ag immun
base germani lead diagnost
compani focus autoimmun infecti
diseas allergi test expect
deal accret ep
india-bas tulip diagnost also
activ restructur portfolio
increas invest see
oper margin improv basi point
look cost account
sale
see ep
think share trade
ep estim slightli peer
near high end compani five-year
averag near fair valu
howev see continu benefit
years-long portfolio restructur
higher-margin high-growth market
strateg effort intern expans
note sale grew organ
everi end-market everi region
oper first time five year
aggress expand footprint china
meet demand prenat neonat
infecti diseas screen recent
open new clinic test lab china
although sale growth china moder
partli govern fund
delay sale improv
anticip continu pickup growth
think china import
growth market also see increas focu
india
declin instrument sale slow growth
diagnost end-market
target price base
slightli peer ep
estim high end five-year
rang
aug ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
senior vice presid
senior vice-president
inc provid technolog servic solut diagnost research
safeti secur industri laboratori servic market compani oper two
segment diagnost discoveri analyt solut
diagnost segment focus develop diagnost tool applic help detect diseas
earlier acceler discoveri develop critic new therapi compani serv
diagnost research market product servic address genet screen
bio-discoveri market provid earli detect genet disord pre-concept earli
childhood well medic imag diagnost market product design provid
insight health expect mother pregnanc newborn compani
instrument reagent softwar test screen disord diseas includ syndrom
infertil anemia diabet compani medic imag detector use enabl doctor
make diagnos condit rang broken bone reduc blood flow vascular system
addit detector improv oncolog treatment focus radiat directli tumor
research market provid suit solut includ reagent liquid handl detect
technolog enabl research improv drug discoveri process applic solut
servic enabl pharmaceut compani creat therapeut portfolio liquid handl
detect technolog includ rang system consist instrument autom
detect solut cellular imag analysi hardwar softwar
addit compani portfolio consum product includ drug discoveri research
reagent sell research solut pharmaceut biotechnolog academ research
discoveri analyt solut segment serv environment food industri life scienc
research laboratori servic market environment market compani develop
provid analyt technolog solut servic enabl custom understand
character health variou aspect environ includ air water soil
compani technolog use detect help reduc impact product industri process
might environ provid tool need test function meet qualiti
specif safeti standard innov next gener product
food market compani provid variou solut help farmer food produc provid
popul food safe nutriti instrument confirm food qualiti includ level
moistur grain level fat butter compani instrument also use detect
presenc potenti danger contamin lead mercuri milk solut could also
use identifi origin food product oliv oil help prevent counterfeit
compani method analys transfer throughout suppli chain
industri market compani provid analyt instrument chemic electron
energi lubric petrochem polym industri industri instrument primarili use
custom focus qualiti assur standard
life scienc research market compani provid suit solut includ reagent
informat detect imag technolog enabl scientist improv life scienc
research facilit drug discoveri process product solut servic support
pharmaceut biotech compani well academ institut intern creat
therapeut help bring product market compani research portfolio includ rang
system consist imag detect extract instrument use vitro ex vivo
vivo model analysi hardwar softwar well rang consum product includ drug
discoveri research reagent
compani also provid servic design enabl custom laboratori servic market
world-wide activ restructur product portfolio recent year
geospiza inc cambridgesoft corpor artu lab chemagen biopolymertechnologi ag
purchas follow seven acquisit three divestitur acquir
shanghai haoyuan biotech decemb acquir perten instrument ab june
acquir april sold perkinelm lab eurofin scientif
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
neutral sinc april technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
posit fundament outlook
life scienc tool servic sub-industri
next month may congress
approv billion increas nation
institut nih fy budget
billion septemb
billion increas fy budget
increas contrast presid
trump call cut nih budget
billion billion fy fy
signific fund academ lab
turn account sale life
scienc tool compani averag
trump propos indic
administr prioriti actual fund
determin congress think
signific bipartisan support nih
believ congress disregard trump propos
cut nih budget nonetheless trump
propos budget creat uncertainti
may result project termin
cloud futur research project
view nih budget rose
billion billion
largest percentag increas sinc
includ billion stimulu fund
american recoveri reinvest act
arra
howev note mani life scienc
compani activ pursu initi
commerci non-academ govern
revenu base also see budget issu
europ result soft govern fund
decemb presid obama sign
centuri cure act law law
provid billion year
nation institut split
go cancer moonshot billion
fund precis medicin initi
billion fund brain initi
support alzheim diseas research
overal see mid-single-digit sale growth
emerg market china
remain robust growth region grow
rate mid-teen help fuel overal
industri growth believ demand
strong begin moder
think research lab suffici
equip current need mani
equip compani also diversifi
product line increas sale
consum typic immun
budget constraint expand
area environment food
safeti agricultur growth
end-market expect robust
pharmaceut research
compani provid servic
pharmaceut biotech firm
contract research organ see
solid growth next month
view believ pharmaceut biotech
firm increasingli outsourc servic
think increas effici lower
cost also see increas strateg
 life scienc tool
servic rose vs rise
 composit index year date
april life scienc
declin composit
base index
five-year market price perform may
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
estim sale fell discoveri analyt solut sale fell
diagnost rose oper margin rose better manufactur
effici higher consum sale see activ restructur
product portfolio purchas divestitur guid sale exclud
pend sale medic imag ep
analyst research note compani news
et cfra keep hold opinion share inc
keep target price slightli
peer ep estim valuat
near high-end five-year rang encourag
organ sale growth aid portfolio restructur ep
vs ahead estim sale aid acquisit rose
organ growth diagnost repres
sale grew organ growth discoveri analyt solut
sale rose sale life scienc market account
sale rose organ growth sale appli market
includ industri food environment market rose
organ growth third consecut quarter organ growth
everi end market howev note oper margin declin bp
look lower cost consolid supplier collabor
rais target ep
estim slightli peer high-end
five-year rang set ep ep
vs ahead estim sale rose organ
growth second consecut quarter organ revenu growth
everi end market everi region world encourag
portfolio restructur believ recent acquisit euroimmun
tulip strengthen offer china europ india /jeffrey loo
rais target in-lin peer
forward ep estim ep vs
ahead estim lower ep estim
rais ep estim sale rose
organ growth driven robust increas diagnost strong
emerg market demand discoveri analyt sale rose
encourag broad-bas growth first time year grew
organ everi end-market everi region world /jeffrey
rais target price in-lin
peer forward ep estim ep vs
line estim rais ep
estim anticip sale aid
new product launch improv end-market improv
sale rose discoveri analyt solut sale flat diagnost
sale although sale slightli forecast encourag
expans oper margin /jeffrey loo cfa
rais target slightli
peer estim although encourag
improv growth rate still peer averag
ep vs ahead estim sale rose
forecast sale growth pki best quarterli sale growth
sinc discoveri analyt sale rose diagnost sale rose
activ restructur product portfolio increas
invest acquisit drive long term growth
inc keep target
in-lin peer ep estim set
ep estim ep vs
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
